398 related articles for article (PubMed ID: 34516843)
1. Developmental chromatin programs determine oncogenic competence in melanoma.
Baggiolini A; Callahan SJ; Montal E; Weiss JM; Trieu T; Tagore MM; Tischfield SE; Walsh RM; Suresh S; Fan Y; Campbell NR; Perlee SC; Saurat N; Hunter MV; Simon-Vermot T; Huang TH; Ma Y; Hollmann T; Tickoo SK; Taylor BS; Khurana E; Koche RP; Studer L; White RM
Science; 2021 Sep; 373(6559):eabc1048. PubMed ID: 34516843
[TBL] [Abstract][Full Text] [Related]
2. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation.
Kaufman CK; Mosimann C; Fan ZP; Yang S; Thomas AJ; Ablain J; Tan JL; Fogley RD; van Rooijen E; Hagedorn EJ; Ciarlo C; White RM; Matos DA; Puller AC; Santoriello C; Liao EC; Young RA; Zon LI
Science; 2016 Jan; 351(6272):aad2197. PubMed ID: 26823433
[TBL] [Abstract][Full Text] [Related]
3. DHODH modulates transcriptional elongation in the neural crest and melanoma.
White RM; Cech J; Ratanasirintrawoot S; Lin CY; Rahl PB; Burke CJ; Langdon E; Tomlinson ML; Mosher J; Kaufman C; Chen F; Long HK; Kramer M; Datta S; Neuberg D; Granter S; Young RA; Morrison S; Wheeler GN; Zon LI
Nature; 2011 Mar; 471(7339):518-22. PubMed ID: 21430780
[TBL] [Abstract][Full Text] [Related]
4. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
5. Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish.
Antonellis A; Huynh JL; Lee-Lin SQ; Vinton RM; Renaud G; Loftus SK; Elliot G; Wolfsberg TG; Green ED; McCallion AS; Pavan WJ
PLoS Genet; 2008 Sep; 4(9):e1000174. PubMed ID: 18773071
[TBL] [Abstract][Full Text] [Related]
6. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
Ceol CJ; Houvras Y; Jane-Valbuena J; Bilodeau S; Orlando DA; Battisti V; Fritsch L; Lin WM; Hollmann TJ; Ferré F; Bourque C; Burke CJ; Turner L; Uong A; Johnson LA; Beroukhim R; Mermel CH; Loda M; Ait-Si-Ali S; Garraway LA; Young RA; Zon LI
Nature; 2011 Mar; 471(7339):513-7. PubMed ID: 21430779
[TBL] [Abstract][Full Text] [Related]
7. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
8. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
[TBL] [Abstract][Full Text] [Related]
9. Functional in vivo characterization of sox10 enhancers in neural crest and melanoma development.
Cunningham RL; Kramer ET; DeGeorgia SK; Godoy PM; Zarov AP; Seneviratne S; Grigura V; Kaufman CK
Commun Biol; 2021 Jun; 4(1):695. PubMed ID: 34099848
[TBL] [Abstract][Full Text] [Related]
10. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X
Oncogene; 2014 Feb; 33(7):832-41. PubMed ID: 23334329
[TBL] [Abstract][Full Text] [Related]
11. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
12. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
13. A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
Claps G; Cheli Y; Zhang T; Scortegagna M; Lau E; Kim H; Qi J; Li JL; James B; Dzung A; Levesque MP; Dummer R; Hayward NK; Bosenberg M; Brown KM; Ronai ZA
Cell Rep; 2016 May; 15(9):1884-92. PubMed ID: 27210757
[TBL] [Abstract][Full Text] [Related]
14. The EJC component Magoh regulates proliferation and expansion of neural crest-derived melanocytes.
Silver DL; Leeds KE; Hwang HW; Miller EE; Pavan WJ
Dev Biol; 2013 Mar; 375(2):172-81. PubMed ID: 23333945
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
16. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic BRAF
Shabaneh TB; Molodtsov AK; Steinberg SM; Zhang P; Torres GM; Mohamed GA; Boni A; Curiel TJ; Angeles CV; Turk MJ
Cancer Res; 2018 Sep; 78(17):5038-5049. PubMed ID: 30026331
[TBL] [Abstract][Full Text] [Related]
18. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration.
Flockhart RJ; Webster DE; Qu K; Mascarenhas N; Kovalski J; Kretz M; Khavari PA
Genome Res; 2012 Jun; 22(6):1006-14. PubMed ID: 22581800
[TBL] [Abstract][Full Text] [Related]
19. Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
Sun C; Wang L; Huang S; Heynen GJ; Prahallad A; Robert C; Haanen J; Blank C; Wesseling J; Willems SM; Zecchin D; Hobor S; Bajpe PK; Lieftink C; Mateus C; Vagner S; Grernrum W; Hofland I; Schlicker A; Wessels LF; Beijersbergen RL; Bardelli A; Di Nicolantonio F; Eggermont AM; Bernards R
Nature; 2014 Apr; 508(7494):118-22. PubMed ID: 24670642
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-tumor cell fusions from peripheral blood of melanoma patients.
Clawson GA; Matters GL; Xin P; Imamura-Kawasawa Y; Du Z; Thiboutot DM; Helm KF; Neves RI; Abraham T
PLoS One; 2015; 10(8):e0134320. PubMed ID: 26267609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]